Finland· FI-REL-REL330
Egazil Duretter
A hyoscyamine product containing hyoscyamine sulfate, registered in Finland by AstraZeneca Oy. The same ATC class is registered in 3 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Hyoscyamine is registered in 3 of 19 countries.
Countries holding a registration under ATC A03BA03 (hyoscyamine), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 3 of them publish a price we can compare per daily dose
Hyoscyamine · ATC A03BA03
3 / 19 countries
- Finlandprice
- Norwayprice
- United Statesprice
The record
At a glance
Fimea (Finland)- Active substance
- Hyoscyamine sulfate
- Manufacturer
- AstraZeneca Oy
- Country
- Finland (FI)
- ATC code
- A03BA03
- ATC class
- Hyoscyamine
- Defined daily dose
- 1.2 mg, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
217 interactions on record for hyoscyamine.
Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Hyoscyamine · interactions on record
217 records
- 6 severe
- 194 moderate
- 17 minor
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- TopiramatN02CX12severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Hyoscyamine in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fe90b469-8628-483d-97ba-f9009635a328 GET /v1/drugs/fe90b469-8628-483d-97ba-f9009635a328?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "1.2",
"form": "depottabletti",
"route": null,
"ddd_unit": "mg",
"strength": "0.2 mg",
"atc_label": "hyoskyamiini",
"ma_number": "2989",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL330",
"authorised_at": "1966-02-16"
}See everything about hyoscyamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.